In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times BPC 157 Double Strength LVLUP Health BPC 157 99%+ Pure Peptide Amino Club Amino Club The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN BPC 157 137525 51 0